Spreadsheet: 883245d1731798110-number-of-projects-at-any-given-time-past-protocol-workload
Sheet: Sheet1

Protocol Therapeutic Area | Protocol Specific Indication | Protocol Phase | Start Date | End Date | [NAME] in Days
Oncology, US | Esophageal Cancer | Phase III | 2014-01-01 00:00:00 | 2015-12-01 00:00:00
Device, US | Coronary Stent | Pivotal | 2014-01-01 00:00:00 | 2016-01-01 00:00:00
Device, US | Skin Grafts | Pivotal | 2014-02-01 00:00:00 | 2016-01-01 00:00:00
Cardiovascular, Global | HTN | Phase III | 2014-03-01 00:00:00 | 2014-08-01 00:00:00
Cardiovascular, US | Dyslipidemia | Phase III | 2014-03-01 00:00:00 | 2014-08-01 00:00:00
Infectious Disease, Global | Diabetic Ulcers | Phase II | 2014-08-01 00:00:00 | 2015-11-01 00:00:00
Device, US | Pacemakers | Pivotal | 2014-09-01 00:00:00 | 2015-12-01 00:00:00
Cardiovascular, US | HTN | Phase II | 2015-01-01 00:00:00 | 2015-10-01 00:00:00
Device, US | Heart Failure | Pilot | 2015-04-01 00:00:00 | 2016-12-01 00:00:00
Cardiovascular, US | CAD | Phase II | 2015-10-01 00:00:00 | 2016-01-01 00:00:00
Cardiovascular, US | CAD | Phase III | 2015-10-01 00:00:00 | 2016-01-01 00:00:00
Cardiovascular, US & Canada | Heart Failure | Phase II | 2015-10-01 00:00:00 | 2016-01-01 00:00:00
Cardiovascular, US | Deep Vein Thrombosis | Phase III | 2016-01-01 00:00:00 | 2016-07-01 00:00:00
Cardiovascular, US | Heart Valve Disease | Phase II | 2016-01-01 00:00:00 | 2017-10-01 00:00:00
Cardiovascular, US | Heart Valve Disease | Phase III | 2016-01-01 00:00:00 | 2017-10-01 00:00:00
Device, US | Heart Failure | Pivotal | 2016-02-01 00:00:00 | 2016-12-01 00:00:00
Device, US | Heart Failure | Post-Market | 2016-02-01 00:00:00 | 2016-12-01 00:00:00
Cardiovascular, US | Heart Failure | Phase II | 2016-04-01 00:00:00 | 2016-10-01 00:00:00
Device, US | Mechanical Circulatory Systems | Post-Market | 2016-06-01 00:00:00 | 2017-01-01 00:00:00
Cardiovascular, US | Heart Failure | Phase III | 2016-07-01 00:00:00 | 2017-06-01 00:00:00
Infectious Disease, US | MRSA | Phase II | 2016-10-01 00:00:00 | 2017-02-01 00:00:00
Device, US | [NAME] | Post-Market | 2017-01-01 00:00:00 | 2017-04-01 00:00:00
Cardiovascular, US | A-Fib | Phase II | 2017-01-01 00:00:00 | 2017-10-01 00:00:00
Cardiovascular, Global | CAD | Phase III | 2017-02-01 00:00:00 | 2017-06-01 00:00:00
Cardiovascular, US | Deep Vein Thrombosis | Phase II | 2017-03-01 00:00:00 | 2017-08-01 00:00:00
Oncology, US | NSCLC | Phase III | 2017-05-01 00:00:00 | 2017-10-01 00:00:00
Device, US | Wound Healing | Pilot | 2017-10-01 00:00:00 | 2019-09-01 00:00:00
Infectious Disease, US | Infected Burn Wounds | Phase IV | 2017-10-01 00:00:00 | 2020-11-01 00:00:00
Device, US | Burns | Pilot | 2018-08-01 00:00:00 | 2020-12-01 00:00:00
Device, US | Burns | Pivotal | 2018-08-01 00:00:00 | 2020-12-01 00:00:00
Endocrine, US | DM Type II | Phase III | 2019-02-01 00:00:00 | 2019-11-01 00:00:00
Analgesia, US | Post-op Pain | Phase I | 2019-08-01 00:00:00 | 2020-10-01 00:00:00
Analgesia, US | Post-op Pain | Phase II | 2019-08-01 00:00:00 | 2020-10-01 00:00:00
Device, US | Wound Healing | Pivotal | 2019-10-01 00:00:00 | 2020-12-01 00:00:00
Infectious Disease, US | Baterial Infections (in-patient) | Phase III | 2019-11-01 00:00:00 | 2020-03-01 00:00:00
Infectious Disease, US | Baterial Infections (in-patient) | Phase IV | 2019-11-01 00:00:00 | 2020-03-01 00:00:00
Device, US | Respiratory Paralysis | Pivotal | 2021-01-01 00:00:00 | 2021-06-01 00:00:00
Cardiovascular, US | A-Fib | Phase III | 2021-01-01 00:00:00 | 2021-11-01 00:00:00
Cardiovascular, US | Heart Valve Disease | Phase III | 2021-01-01 00:00:00 | 2022-02-01 00:00:00
Device, US | Sternal Closure | Pilot | 2021-02-01 00:00:00 | 2021-06-01 00:00:00
Device, US | Ablation | Pivotal | 2021-04-01 00:00:00 | 2022-02-01 00:00:00
Cardiovascular, US | Anticoagulation | Phase III | 2021-06-01 00:00:00 | 2021-11-01 00:00:00
Neurology, US | [NAME] | Phase III | 2021-07-01 00:00:00 | 2022-02-01 00:00:00
Hematology, US | Post-op Anemia | Phase III | 2021-11-01 00:00:00 | 2021-12-01 00:00:00
Neurology, US | ALS | Phase I | 2021-11-01 00:00:00 | 2022-02-01 00:00:00
Analgesia, US | Chronic Pain | Phase III | 2022-02-01 00:00:00 | 2023-03-01 00:00:00
Device, US | Ablation | Post-Market | 2022-02-01 00:00:00 | 2023-03-01 00:00:00
Device, US | [NAME] | Post-Market | 2022-02-01 00:00:00 | 2023-03-01 00:00:00
Neurology, US | Parkinson's Disease | Phase II | 2022-04-01 00:00:00 | 2023-03-01 00:00:00
Genitourinary, US | Chronic Kidney Disease | Phase III | 2022-08-01 00:00:00 | 2023-01-01 00:00:00
Device, US & Canada | Heart Valve Disease | Post-Market | 2023-04-01 00:00:00 | 2024-08-01 00:00:00
Device, US | LAA Closure Device | Pivotal | 2023-04-01 00:00:00 | 2024-08-01 00:00:00
Cardiovascular, US | A-Fib | Phase II | 2023-04-01 00:00:00 | 2023-09-01 00:00:00
Neurology, US | Parkinson's Disease | Phase III | 2023-06-01 00:00:00 | 2023-12-01 00:00:00
Analgesia, US | Opioid Abuse/Addiction | Phase III | 2023-07-01 00:00:00 | 2024-08-01 00:00:00
Cardiovascular, US | A-Fib | Phase III | 2023-09-01 00:00:00 | 2024-08-01 00:00:00